W. Severson

发表

Advancing Biological Understanding and Therapeutics Discovery with Small-Molecule Probes

Tudor I. Oprea, Jennifer E. Golden, Joshua A. Bittker, 2015, Cell.

Development and Validation of a High-Throughput Screen for Inhibitors of SARS CoV and Its Application in Screening of a 100,000-Compound Library

E Lucile White, Subramaniam Ananthan, C. Jonsson, 2007, SLAS Discovery.

A high-throughput screening strategy to overcome virus instability.

E. White, W. Severson, L. Rasmussen, 2011, Assay and drug development technologies.

(S)-N-(2,5-Dimethylphenyl)-1-(quinoline-8-ylsulfonyl)pyrrolidine-2-carboxamide as a small molecule inhibitor probe for the study of respiratory syncytial virus infection.

Jennifer E. Golden, Nichole A. Tower, C. Jonsson, 2012, Journal of medicinal chemistry.

in Screening of a 100,000-Compound Library Development and Validation of a High-Throughput Screen for Inhibitors of SARS CoV and Its Application

B. Jonsson, E. White, W. Severson, 2013 .

Surface property determination for planetary rovers

William E. Severson, Robert J. Douglass, David J. Anhalt, 1991 .

A cell based high-throughput screening approach for the discovery of new inhibitors of respiratory syncytial virus

Jennifer E. Golden, C. Jonsson, D. Chung, 2013, Virology Journal.

Purification and characterization of the Sin Nombre virus nucleocapsid protein expressed in Escherichia coli.

C. Jonsson, C. Schmaljohn, W. Severson, 2001, Protein expression and purification.

cis-Acting Signals in Encapsidation of Hantaan Virus S-Segment Viral Genomic RNA by Its N Protein

C. Jonsson, W. Severson, Xiaolin Xu, 2001, Journal of Virology.

A novel cell-based 384-well, label-free assay for discovery of inhibitors of influenza A virus

C. Jonsson, E. White, W. Severson, 2010 .

Optimization of Novel Broad Spectrum Anti-influenza Therapeutics

Xi Chen, Clinton Maddox, William Severson, 2010 .

Validated Preclinical Murine Model for Therapeutic Testing against Multidrug Resistant Pseudomonas aeruginosa

J. Gabbard, W. Severson, D. Andes, 2022, bioRxiv.

Validated Preclinical Mouse Model for Therapeutic Testing against Multidrug-Resistant Pseudomonas aeruginosa Strains

A. Stromberg, J. Gabbard, W. Severson, 2022, Microbiology spectrum.

Characterization of the Hantaan Nucleocapsid Protein-Ribonucleic Acid Interaction*

C. Jonsson, C. Schmaljohn, W. Severson, 1999, The Journal of Biological Chemistry.

Optimization of Potent and Selective Quinazolinediones: Inhibitors of Respiratory Syncytial Virus That Block RNA-Dependent RNA-Polymerase Complex Activity

Chad E. Schroeder, Jennifer E. Golden, R. Plemper, 2014, Journal of medicinal chemistry.

CoV-RBD121-NP Vaccine Candidate Protects against Symptomatic Disease following SARS-CoV-2 Challenge in K18-hACE2 Mice and Induces Protective Responses That Prevent COVID-19-Associated Immunopathology

J. Morton, K. Swope, K. Palmer, 2021, Vaccines.

Discovery of Novel Benzoquinazolinones and Thiazoloimidazoles, Inhibitors of Influenza H5N1 and H1N1 Viruses, from a Cell-Based High-Throughput Screen

D. Smee, C. Jonsson, D. Noah, 2011, Journal of biomolecular screening.

The development of a diagnostic assay for Tritrichomonas foetus

W. Severson, 1991 .

High-Throughput Screening of a 100,000-Compound Library for Inhibitors of Influenza A Virus (H3N2)

M. McDowell, C. Jonsson, D. Chung, 2008, Journal of biomolecular screening.

Ribavirin Causes Error Catastrophe during Hantaan Virus Replication

William E. Severson, Ali Javadian, Colleen B. Jonsson, 2003, Journal of Virology.

A cell-based luminescence assay is effective for high-throughput screening of potential influenza antivirals.

C. Jonsson, D. Noah, J. Noah, 2007, Antiviral research.

mRNA VACCINE INDUCED DAMAGE MECHANISMS

D. Demarco, K. Palmer, W. Severson, 2021 .

Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses.

D. Meltzer, G. Randall, S. Tay, 2022, Science advances.

Lymphocyte p56L32 is a RNA/DNA-binding protein which interacts with conserved elements of the murine L32 ribosomal protein mRNA.

W. Severson, M. White, P. Mascolo, 1995, European journal of biochemistry.

Novel Inhibitors of Severe Acute Respiratory Syndrome Coronavirus Entry That Act by Three Distinct Mechanisms

S. Sarafianos, C. Jonsson, S. Weiss, 2013, Journal of Virology.

The RNA Binding Domain of the Hantaan Virus N Protein Maps to a Central, Conserved Region

C. Jonsson, C. Schmaljohn, W. Severson, 2002, Journal of Virology.

Essential Amino Acids of the Hantaan Virus N Protein in Its Interaction with RNA

Sonia Longhi, Bruno Canard, William Severson, 2005, Journal of Virology.

Validated Preclinical Mouse Model for Therapeutic Testing against Multidrug-Resistant Pseudomonas aeruginosa Strains

A. Stromberg, J. Gabbard, W. Severson, 2022, Microbiology spectrum.

Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2

M. Vignuzzi, A. Joachimiak, N. Heaton, 2021, Science.

A Cell Based HTS Approach for the Discovery of New Inhibitors of RSV

Jennifer E. Golden, Nichole A. Tower, C. Jonsson, 2013 .

Identification of a Series of Quinazolinediones as Potent, Selective, Post-Entry Inhibitors of Human Respiratory Syncytial Virus ( h RSV) via a Cell-Based High Throughput Screen and Chemical Optimization

Jennifer E. Golden, Nichole A. Tower, Carrie W. Evans, 2013 .

The separation capacity of the Rorschach.

R. Corsini, W. Severson, H. Uehling, 1955, Journal of Consulting Psychology.